Skip to content
MarketScale
‹ Back to IndustriesHealthcare

THE OUTLOOK FOR ENZYME SUPPLEMENTS IS STRONGER THAN EVER

According to the market research firm Credence Research, Inc., the digestive enzyme supplements market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.9% over the coming years, reaching about $1.6 billion by 2025.[1] This growth is being driven by conditions like lactose intolerance, as well as a growing awareness and concern over those…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

According to the market research firm Credence Research, Inc., the digestive enzyme supplements market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.9% over the coming years, reaching about $1.6 billion by 2025.[1] This growth is being driven by conditions like lactose intolerance, as well as a growing awareness and concern over those wanting to improve their digestive health by using probiotics and prebiotics. Let’s take a look at the outlook of the enzyme supplement market.

The World Regions Driving the Growth of Enzyme Supplements

In 2016, the North American region was the world leader in revenue share for enzyme supplements. This can be attributed to consumers with gastrointestinal issues, an increased emphasis on maintaining a healthy lifestyle, and the growing access to dietary supplements from manufacturers and suppliers. The most rapidly growing market segment, however, was the Asia-Pacific region, which is expected to grow by over 7.5 % by 2024.[2] This is due to factors such as a large aging population and a dietary preference for oily and spicy food.

Enzyme Supplements Aid Digestion for a Large Segment of the Population

The human body produces 22 different types of enzymes.[3] Digestive enzymes are beneficial in easing the stress on the stomach, gallbladder, liver, small intestine, and pancreas when processing starches, fats, and proteins. Unfortunately, from time to time, the body may have shortages of certain digestive enzymes due to a number of issues. One such factor is lactase deficiency, commonly known as lactose intolerance, a condition that affects approximately 70% of the world’s population.[4] Gluten sensitivity is becoming more prevalent as well. Finally, the natural aging process itself greatly reduces the body’s ability to produce digestive enzymes, lowering digestive activity by as much as 50%.[5]

Enzyme Supplements Offer a Number of Important Benefits

Even those without a shortage of digestive enzymes realize a number of important benefits in taking enzyme supplements. Many consumers may experience gastrointestinal discomfort due to consuming fast food, sugars, and artificial preservatives and sweeteners that can negatively affect the gut flora that comprise the microbiome. In addition, there is a rising demand for natural sports nutrition products among athletes, fitness enthusiasts, and even casual exercisers looking to improve their performance and overall sense of well-being. Finally, an aging world population is looking for ways to stay healthy and vibrant during their golden years.

Deerland Enzymes & Probiotics is Positioned to Address this Growing Need

There can be no doubt that the outlook for enzyme supplements will be very strong in the years ahead. At Deerland, we work closely with our customers at the early concept phase of product development to ensure we are helping them to deliver the benefits consumers desire and that meet their specific needs. Our product development team creates a wide range of specialized supplement formulas that include enzymes, probiotics and prebiotics.

To learn more, please visit http://www.deerlandenzymes.com/products/ today.

[1] https://www.credenceresearch.com/press/global-digestive-enzymes-supplements-market

[2] https://www.gminsights.com/industry-analysis/enzymes-market

[3] https://www.credenceresearch.com/report/digestive-enzymes-supplements-market

[4] https://www.credenceresearch.com/report/digestive-enzymes-supplements-market

[5] https://www.credenceresearch.com/report/digestive-enzymes-supplements-market

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512